Section Arrow
Quote
ASBP.NASDAQ
- Aspire Biopharma Holdings Inc.
Quotes are at least 15-min delayed:2026/05/17 10:31 EDT
Regular Hours
Last
 5.61
-0.26 (-4.43%)
Day High 
5.93 
Prev. Close
5.87 
1-M High
27.936 
Volume 
117.01K 
Bid
5.45
Ask
5.9
Day Low
5.2 
Open
5.63 
1-M Low
3.309 
Market Cap 
7.11M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.63 
20-SMA 6.25 
50-SMA 20.31 
52-W High 1,050.36 
52-W Low 1.241025 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-491.40/--
Enterprise Value
7.11M
Balance Sheet
Book Value Per Share
-5.27
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
6.20K
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HCWBHCW Biologics Inc1.22+0.883+262.02%-- 
ADTXAditxt Inc.0.0632-0.0036-5.39%-- 
RXRXRecursion Pharmaceuticals2.93-0.11-3.62%-- 
GERNGeron Corp1.29-0.11-7.86%-- 
NTLAIntellia Therapeutics13.67+0.58+4.43%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.